Delivery Order SPE2DR25D3014-SPE2DR26FP1ND
- Not listed
- The Defense Logistics Agency awarded a $11,589.48 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 4, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $8,176.37 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a $4,803.48 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's established capability...
- The Defense Logistics Agency awarded a $15,827.33 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion deadline of December 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, valued at $1,214.32 with a firm fixed price. The contract, which was competitively awarded without a set-aside designation, has an ultimate completion date of August 14, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as the vendor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, valued at $35,763.28, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,926.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of June 24, 2025. This non-set-aside contract utilizes competitive procurement procedures and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $15,882.49 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $3,267.57 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This firm fixed-price delivery order, valued at $27,090.28 with a completion date of January 6, 2026, represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation,...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1NDDelivery Order
The Defense Logistics Agency awarded a $4,103.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child order under AmerisourceBergen's parent company Cencora, Inc., carries an ultimate completion date of January 7, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded through open competition with no set-aside designation, reflecting the vendor's ability to compete on a full and open basis for federal pharmaceutical procurement requirements. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Repatha is a PCSK9 inhibitor used in cardiovascular disease management, and its procurement through DLA supports the Defense Health Agency and military treatment facilities' medication inventory needs. The single-award IDC enables AmerisourceBergen to efficiently fulfill government requirements for a broad spectrum of pharmaceutical products, medical supplies, vaccines, and specialty medications essential to military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 1/5/26 |